Postmenopausal Hormone Therapy and Colorectal Cancer Risk by Molecularly Defined Subtypes and Tumor Location

BACKGROUND: Postmenopausal hormone therapy (HT) is associated with a decreased colorectal cancer (CRC) risk. As CRC is a heterogeneous disease, we evaluated whether the association of HT and CRC differs across etiologically relevant, molecularly defined tumor subtypes and tumor location. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Labadie, Julia D, Harrison, Tabitha A, Banbury, Barbara, Amtay, Efrat L, Bernd, Sonja, Brenner, Hermann, Buchanan, Daniel D, Campbell, Peter T, Cao, Yin, Chan, Andrew T, Chang-Claude, Jenny, English, Dallas, Figueiredo, Jane C, Gallinger, Steven J, Giles, Graham G, Gunter, Marc J, Hoffmeister, Michael, Hsu, Li, Jenkins, Mark A, Lin, Yi, Milne, Roger L, Moreno, Victor, Murphy, Neil, Ogino, Shuji, Phipps, Amanda I, Sakoda, Lori C, Slattery, Martha L, Southey, Melissa C, Sun, Wei, Thibodeau, Stephen N, Van Guelpen, Bethany, Zaidi, Syed H, Peters, Ulrike, Newcomb, Polly A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477374/
https://www.ncbi.nlm.nih.gov/pubmed/32923935
http://dx.doi.org/10.1093/jncics/pkaa042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477374/
https://www.ncbi.nlm.nih.gov/pubmed/32923935
http://dx.doi.org/10.1093/jncics/pkaa042

Ejemplares similares